• Acanthosis nigricans
  • UBE3A Gene Mutation Analysis, Angelman Syndrome, Tissue
  • PPP2R2B (Protein Phosphatase 2 Regulatory Subunit Beta) Gene Mutation Analysis
  • HLA typing, DR/DQ, Single or Multi Antigen
  • Anti-SARS-CoV-2 (Coronavirus), IgG and IgM
  • ATP-binding cassette transporter A1 (ABCA1) Genotyping
  • Systemic lupus erythematosus (SLE)
  • Hyperplasia of ovarian stroma
  • Lung Cancer, RET (10q11) Rearrangement, FISH, Tissue
  • HIV1/HIV2 Antibody Differentiation
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Anti-Streptolysin O (ASO)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Anti-Streptolysin O (ASO)
Medical Test

Overview
Access to Anti-Streptolysin O (ASO) is restricted.